(Total Views: 297)
Posted On: 06/10/2022 2:24:51 PM
Post# of 33
Re: whytestocks #20
KTRA = BREAST CANCER - OVARIAN CANCER - BRAIN CANCER/TUMOR
PRODUCTS in DEVELOPMENT
The MEDICAL COMPANIES that will be at the JMP EVENT NEXT WEEK below
"JMP Securities’ sales and trading platform serves a broad institutional client base ."
https://www.jmpg.com/jmp-securities/sales-trading
KTRA and AEZS being (by far) less in price than the rest and KTRA expected to have a PHASE 2 ANNOUNCEMENT COMING
"Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
Estimated Primary Completion Date
June 2022 "
https://www.kintaraclinicaltrials.com/our-tri...ioblastoma
OS - 65,532,826 - 05/11/2022
https://www.otcmarkets.com/stock/KTRA/security
We could see a BIG MOVE UPWARDS into the DOLLAR+ RANGE. Imo
https://jmp-ls.ljfevents-rsvp.com/participating-companies
ATNM AEZS ALT AMTI APYX AQST ABUS AVRO AXGN BCRX BWV BPMC CSTL CLLS CMMB CLSD CLNN CGTX CGEN CNCE CRMD CRNX CTIC CUE CVAC CYTK DBVT DCPH EFTR ENTA NDRA FENC FNCH GMDA HOOK BIO ICAD ICCM IMUX IMPL INDP IART IOVA KMPH KTRA KURA LBPH MGNX MDGL MRSN MORF MOR NXTC KIDS OXUR
PRODUCTS in DEVELOPMENT
The MEDICAL COMPANIES that will be at the JMP EVENT NEXT WEEK below
"JMP Securities’ sales and trading platform serves a broad institutional client base ."
https://www.jmpg.com/jmp-securities/sales-trading
KTRA and AEZS being (by far) less in price than the rest and KTRA expected to have a PHASE 2 ANNOUNCEMENT COMING
"Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
Estimated Primary Completion Date
June 2022 "
https://www.kintaraclinicaltrials.com/our-tri...ioblastoma
OS - 65,532,826 - 05/11/2022
https://www.otcmarkets.com/stock/KTRA/security
We could see a BIG MOVE UPWARDS into the DOLLAR+ RANGE. Imo
https://jmp-ls.ljfevents-rsvp.com/participating-companies
ATNM AEZS ALT AMTI APYX AQST ABUS AVRO AXGN BCRX BWV BPMC CSTL CLLS CMMB CLSD CLNN CGTX CGEN CNCE CRMD CRNX CTIC CUE CVAC CYTK DBVT DCPH EFTR ENTA NDRA FENC FNCH GMDA HOOK BIO ICAD ICCM IMUX IMPL INDP IART IOVA KMPH KTRA KURA LBPH MGNX MDGL MRSN MORF MOR NXTC KIDS OXUR
(0)
(0)
